We are live on ! Find out more
HCM

Heathbridge Capital Management Portfolio holdings

AUM $292M
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.7%
5 Year Est. Return
+41.43%
10 Year Est. Return
+174.36%
AUM
$249M
AUM Growth
+$2.7M
Cap. Flow
-$14.9M
Cap. Flow %
-6%
Top 10 Hldgs %
68.43%
Holding
30
New
1
Increased
2
Reduced
16
Closed
4

Sector Composition

Rank Sector Weight
1 Financials 19.39%
2 Communication Services 17.04%
3 Energy 14.05%
4 Technology 10.67%
5 Materials 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORGNW
26
DELISTED
Origin Materials Inc Warrants
ORGNW
$319 ﹤0.01%
16,600
ATS icon
27
ATS Corp
ATS
$2.64B
-323,300
Closed -$8.07M
NVO
28
Novo Nordisk
NVO
$208B
-117,950
Closed -$8.19M
SLF icon
29
Sun Life Financial
SLF
$46B
-4,000
Closed -$229K
VRSK icon
30
Verisk Analytics
VRSK
$25.4B
-750
Closed -$223K

Similar funds

Heathbridge Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Heathbridge Capital Management held 30 positions worth $249M, up 1.1% from $246M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Heathbridge Capital Management withdrew a net $14.9M in Q2 2025, closing 4 positions and reducing 16 holdings. Its most notable exit was Novo Nordisk, an estimated $8.19M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Communication Services and Energy.

Against the trend, Heathbridge Capital Management opened a new position in South Bow Corp worth $5.38M.

  • Heathbridge Capital Management's largest Q2 2025 buy was South Bow Corp: 207,600 shares worth $5.38M.
  • Heathbridge Capital Management added most to Manulife Financial in Q2 2025, an estimated $123K increase.
  • Heathbridge Capital Management's biggest Q2 2025 reduction was Automatic Data Processing, cutting an estimated $1.71M.
  • Heathbridge Capital Management fully exited Novo Nordisk in Q2 2025, selling an estimated $8.19M.
  • Heathbridge Capital Management's ten largest holdings make up 68% of its $249M portfolio in Q2 2025.
  • Heathbridge Capital Management opened 1 new position and closed 4 in Q2 2025.
  • Heathbridge Capital Management's portfolio value rose 1.1% quarter-over-quarter to $249M.

Based on Heathbridge Capital Management's 13F filing for Q2 2025, filed 23 Jul 2025.